Clinical Trial Update: Individual Sensitivity for Interstitial Lung Diseases

View source ↗

Summary

A completed clinical trial update from Maastricht University Medical Center on individual sensitivity factors in interstitial lung disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Interstitial Lung Diseases | Status: COMPLETED